Trial Site Detail

 

Drug:
Nivolumab + BMS-986016
Trial:
Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Conditions: Solid Tumors
Trial Status:
Recruiting

 

University of Chicago

5841 S. Maryland Ave     
Chicago , IL 60637
USA

 

Principal Investigator:
Contact:
Thomas F Gajewski, Site 0003 773-702-2085
Activation Status of this Site:
Active
Notes about this Site:
University of Chicago Website:
https://med-www02.bsd.uchicago.edu/crc_web/SR/internet/DiseaseSites.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.